24/7
Buzz
Startups
VC
AI
Innovation
Opinions
Events
Promising Startups 2024
BiblioTech
Boarding Pass
Corporate
Appointments
CTalk
Tech Gateways
2025 VC survey
@Finance
Ctech Testimonials
Shopping
Projects
Spotlight
About
Newsletter
Contact us
Facebook
Twitter
ACCESSIBILITY
by
Homepage
Anchiano
Tags search
HOME
24/7
buzz
STARTUPS
VC
AI
Innovation
OPINIONS
EVENTS
SHOPPING
ABOUT
teram of use
Privacy Policy
NEWSLETTER
SEARCH
CONTACT US
ACCESSIBILITY
24/7
Headlines
22:12
Full list of Israeli high-tech funding rounds in 2026
22:10
Full list of Israeli startup M&As in 2026
21:51
Akamai acquires Israeli AI browser security startup LayerX for $205 million in cash
16:00
Novella raises $21 million to automate complex insurance with AI brokers
More stories
Buzz
Most popular
Daily
Weekly
1
Akamai in advanced talks to acquire Israeli startup LayerX for $250 million
2
The Israeli startups to watch out for in 2026
3
"Israel is the cutting edge of the West. A lot of people don’t understand that."
4
Base44 milestone unlocks $38 million payout for founder Maor Shlomo
5
The 50 most promising Israeli startups - 2026
More news
Anchiano
2 stories about Anchiano
Anchiano Therapeutics Schedules TASE Delisting
14.03.19
|
Lilach Baumer
Based in Jerusalem and Cambridge, Massachusetts, clinical-stage Anchiano develops gene therapies for cancer, with a special focus on bladder cancer
Cancer Treatment Company Anchiano Therapeutics Wants to List on Nasdaq
09.01.19
|
Lilach Baumer
The company formerly known as BioCanCell submitted a prospectus to the SEC on Monday, with Oppenheimer & Co. as the sole underwriter
